- Home
- ATRC vs CIM Comparison
ATRC vs CIM Comparison
Compare ATRC & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- CIM
- Stock Information
- Founded
- ATRC 2000
- CIM 2007
- Country
- ATRC United States
- CIM United States
- Employees
- ATRC N/A
- CIM N/A
- Industry
- ATRC Medical/Dental Instruments
- CIM Real Estate Investment Trusts
- Sector
- ATRC Health Care
- CIM Real Estate
- Exchange
- ATRC Nasdaq
- CIM Nasdaq
- Market Cap
- ATRC 1.7B
- CIM 1.1B
- IPO Year
- ATRC 2005
- CIM 2007
- Fundamental
- Price
- ATRC $35.95
- CIM $14.04
- Analyst Decision
- ATRC Strong Buy
- CIM Buy
- Analyst Count
- ATRC 10
- CIM 3
- Target Price
- ATRC $49.60
- CIM $15.50
- AVG Volume (30 Days)
- ATRC 411.9K
- CIM 502.6K
- Earning Date
- ATRC 10-28-2025
- CIM 11-05-2025
- Dividend Yield
- ATRC N/A
- CIM 10.55%
- EPS Growth
- ATRC N/A
- CIM N/A
- EPS
- ATRC N/A
- CIM 1.28
- Revenue
- ATRC $499,946,000.00
- CIM $312,281,000.00
- Revenue This Year
- ATRC $16.32
- CIM $15.99
- Revenue Next Year
- ATRC $12.37
- CIM $9.70
- P/E Ratio
- ATRC N/A
- CIM $10.92
- Revenue Growth
- ATRC 16.28
- CIM 1.91
- 52 Week Low
- ATRC $25.57
- CIM $9.85
- 52 Week High
- ATRC $43.11
- CIM $16.89
- Technical
- Relative Strength Index (RSI)
- ATRC 50.63
- CIM 47.32
- Support Level
- ATRC $34.21
- CIM $13.83
- Resistance Level
- ATRC $38.08
- CIM $14.31
- Average True Range (ATR)
- ATRC 1.57
- CIM 0.27
- MACD
- ATRC -0.20
- CIM -0.06
- Stochastic Oscillator
- ATRC 39.79
- CIM 16.19
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
About CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.